Journal of Pain and Symptom Management
Volume 27, Issue 2 , Pages 101-103 , February 2004

Successful treatment of CRPS 1 with anti-TNF

References 

  1. Stanton Hicks M, Janig W, Hassenbusch S, et al.  Reflex sympathetic dystrophy: changing concepts and taxonomy. Pain. 1995;63:127–133
  2. Huygen FJPM, De Bruijn AGJ, Klein J, et al.  Neuroimmune alterations in the complex regional pain syndrome. Eur J Pharm. 2001;429:101–113
  3. Huygen FJPM, De Bruijn AGJ, De Bruijn MT, et al.  Evidence for local inflammation in complex regional pain syndrome type 1. Mediators Inflamm. 2002;11:47–51
  4. Blam ME, Stein RB, Lichenstein GR. Integrating anti-tumor necrosis factor in inflammatory bowel disease: current and future perspectives. Am J Gastroenterol. 2001;96:1977–1997
  5. Emery P, Buch M. Treating rheumatoid arthritis with tumor necrosis factor alpha blockade. BMJ. 2002;234:212–213
  6. Vaneker M, Van Der Laan L, Allebes WA, et al.  Genetic factors associated with Complex Regional Pain Syndrome (I: HLA DRB and TNF alfa promotor gene polymorphism). Disability Med. 2002;2:69–74
  7. Wagner R, Myers RR. Schwann cells produce tumor necrosis factor alpha: expression in injured and non-injured nerves. Neuroscience. 1996;73:625–629
  8. Lindenlaub T, Teuteberg P, Hartung T, et al.  Effects of neutralizing antibodies to TNF-alpha on pain-related behavior and nerve regeneration in mice with chronic constriction injury. Brain Res. 2000;866:15–22

PII: S0885-3924(03)00498-6

doi: 10.1016/j.jpainsymman.2003.12.006

Journal of Pain and Symptom Management
Volume 27, Issue 2 , Pages 101-103 , February 2004

Article Tools